GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (MEX:IDXX) » Definitions » Cyclically Adjusted PS Ratio

IDEXX Laboratories (MEX:IDXX) Cyclically Adjusted PS Ratio : 16.90 (As of Jun. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is IDEXX Laboratories Cyclically Adjusted PS Ratio?

As of today (2024-06-21), IDEXX Laboratories's current share price is MXN9320.00. IDEXX Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was MXN551.45. IDEXX Laboratories's Cyclically Adjusted PS Ratio for today is 16.90.

The historical rank and industry rank for IDEXX Laboratories's Cyclically Adjusted PS Ratio or its related term are showing as below:

MEX:IDXX' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.43   Med: 13.46   Max: 30.79
Current: 14.86

During the past years, IDEXX Laboratories's highest Cyclically Adjusted PS Ratio was 30.79. The lowest was 5.43. And the median was 13.46.

MEX:IDXX's Cyclically Adjusted PS Ratio is ranked worse than
93.89% of 131 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.38 vs MEX:IDXX: 14.86

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

IDEXX Laboratories's adjusted revenue per share data for the three months ended in Mar. 2024 was MXN190.578. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is MXN551.45 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


IDEXX Laboratories Cyclically Adjusted PS Ratio Historical Data

The historical data trend for IDEXX Laboratories's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Cyclically Adjusted PS Ratio Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.41 24.50 27.04 14.34 17.29

IDEXX Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.89 16.39 13.85 17.29 16.18

Competitive Comparison of IDEXX Laboratories's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, IDEXX Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Cyclically Adjusted PS Ratio falls into.



IDEXX Laboratories Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

IDEXX Laboratories's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=9320.00/551.45
=16.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, IDEXX Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=190.578/131.7762*131.7762
=190.578

Current CPI (Mar. 2024) = 131.7762.

IDEXX Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 48.843 100.560 64.005
201409 51.087 100.428 67.034
201412 53.587 99.070 71.278
201503 61.043 99.621 80.746
201506 68.770 100.684 90.007
201509 73.922 100.392 97.032
201512 74.857 99.792 98.849
201603 79.127 100.470 103.782
201606 95.010 101.688 123.122
201609 95.111 101.861 123.044
201612 100.746 101.863 130.332
201703 96.666 102.862 123.838
201706 102.357 103.349 130.511
201709 100.031 104.136 126.582
201712 111.606 104.011 141.399
201803 109.821 105.290 137.448
201806 128.804 106.317 159.648
201809 115.345 106.507 142.711
201812 122.834 105.998 152.707
201903 127.635 107.251 156.822
201906 135.953 108.070 165.776
201909 136.310 108.329 165.813
201912 130.845 108.420 159.032
202003 169.383 108.902 204.962
202006 170.331 108.767 206.363
202009 183.932 109.815 220.716
202012 164.870 109.897 197.694
202103 182.900 111.754 215.668
202106 189.780 114.631 218.164
202109 192.621 115.734 219.320
202112 190.751 117.630 213.692
202203 194.667 121.301 211.478
202206 204.017 125.017 215.048
202209 201.277 125.227 211.804
202212 192.706 125.222 202.793
202303 193.261 127.348 199.981
202306 192.628 128.729 197.188
202309 189.867 129.860 192.669
202312 182.316 129.419 185.636
202403 190.578 131.776 190.578

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IDEXX Laboratories  (MEX:IDXX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


IDEXX Laboratories Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (MEX:IDXX) Business Description

Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.